Russia to sell 100 million doses of COVID-19 vaccine to India: Source
- 16 Sep 2020
Picture used for illustrative purpose. File
Russia's sovereign wealth fund has agreed a deal to sell 100 million doses of its COVID-19 vaccine, Sputnik-V, to a major listed pharmaceutical company in India, a source close to the deal said on Wednesday.
READ MORE
Cyprus says ready for a dialogue with Turkey but not under threats
Trump says coronavirus vaccine could be ready in a month
India's coronavirus cases surpass five million mark
Clinical trials of the Russian vaccine in India are expected to follow and to be held jointly with this firm, the source said. Both the trials and supply deal depend on domestic regulatory approval.
Reuters
